V. Shyamala

发表

High-throughput screening for ligand-induced c-fos mRNA expression by branched DNA assay in Chinese hamster ovary cells.

W. Kavanaugh, V. Shyamala, H. Khoja, 1999, Analytical biochemistry.

Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.

Preeti Pancholi, Rajyasree Emmadi, B. Zimmer, 2011, The Journal of molecular diagnostics : JMD.

Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay

S. Glynn, V. Shyamala, M. Busch, 2007, Transfusion.

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic

R. Lanciotti, S. Glynn, S. Kleinman, 2005, Transfusion.

A nucleic acid amplification repeat testing algorithm reveals high risk of hepatitis B and C transmission with serologic blood screening practice in Punjab, India

R. Kumar, V. Shyamala, P. Kumar, 2018 .

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003

M. Drebot, J. Saldanha, V. Shyamala, 2005, Transfusion.

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

D. Vlahov, S. Ray, S. Strathdee, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Application of Polymerase Chain Reaction to Hepatitis C Virus Research and Diagnostics

M. Houghton, A. Weiner, V. Shyamala, 1992 .

Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India

V. Shyamala, 2014, Transfusion medicine.

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

V. Shyamala, C. Giachetti, B. Phelps, 2003, Blood.

Inhibition of Adenylyl Cyclase by α Chemokines IL-8 and GRO-α in Chinese Hamster Ovary Cells Expressing R1 and R2 Receptors

V. Shyamala, H. Khoja, M. Moghadam, 1998 .

Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons

V. Shyamala, P. E. Valensin, J. Han, 1998, Infection.

HCV RNA detection in heparinized blood by direct genomic RNA capture onto paramagnetic particles.

L. van Doorn, V. Shyamala, J. Han, 1994, Journal of virological methods.

Serum hepatitis C virus (HCV)‐RNA and response to alpha‐interferon in anti‐HCV positive chronic hepatitis

V. Shyamala, Jang H. Han, G. Bucca, 1992, Journal of medical virology.

Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.

D. Sansonno, G. Lauletta, F. Dammacco, 1994, Blood.

Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.

Matthew J. Brauer, M. Brauer, B. Irvine, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Peter Tomasulo, Hany Kamel, Sally Caglioti, 2005, The New England journal of medicine.

Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus

V. Shyamala, 2014, Asian journal of transfusion science.

Antimalarial activity of optical isomers of quinacrine dihydrochloride against chloroquine-sensitive and -resistant Plasmodium falciparum in vitro.

V. Shyamala, J. Craig, D. Warhurst, 1991, Biochemical pharmacology.

Two types of plasminogen activators secreted by MCP-7 cells.

V. Shyamala, H. Dickerman, 1982, Biochemical and biophysical research communications.

Assessment of the Target-Capture PCR Hepatitis B Virus (HBV) DNA Quantitative Assay and Comparison with Commercial HBV DNA Quantitative Assays

V. Shyamala, B. Phelps, D. Coit, 2004, Journal of Clinical Microbiology.

Nucleic Acid Technology (NAT) testing for blood screening: impact of individual donation and Mini Pool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity

V. Shyamala, 2014 .

CorrigendumCorrigendum to “Detection and quantitation of HBV DNA in the WHO International Standard for HIV-1 RNA (NIBSC code: 97/656)”: [J. Virol. Meth. 118 (2004) 69–72]

V. Shyamala, B. Phelps, J. Linnen, 2004 .

Detection and quantitation of HBV DNA in the WHO International Standard for HIV-1 RNA (NIBSC code: 97/656).

V. Shyamala, B. Phelps, J. Linnen, 2004, Journal of virological methods.

Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2

L. Williams, V. Shyamala, B. Shamoon, 1997, The EMBO journal.

Receptor Recognition and Specificity of Interleukin-8 Is Determined by Residues That Cluster Near a Surface-accessible Hydrophobic Pocket (*)

P. Feucht, V. Shyamala, H. Khoja, 1996, The Journal of Biological Chemistry.

Cloning of CCRL1, an orphan seven transmembrane receptor related to chemokine receptors, expressed abundantly in the heart.

V Shyamala, V. Shyamala, H. Khoja, 2000, Gene.

Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells.

V. Shyamala, H. Khoja, Venkatakrishna Shyamala, 1998, Biochemistry.

Semirational design of a potent, artificial agonist of fibroblast growth factor receptors

Michael V. Doyle, G. Apell, W. Kavanaugh, 1999, Nature Biotechnology.

Individual donation nucleic acid technology testing to minimize human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus transfusion transmitted infections

V. Shyamala, J. Holmberg, T. Sandison, 2014, Asian journal of transfusion science.

An improved method of assaying for human erythrocyte invasion by Plasmodium falciparum.

V. Shyamala, 1985, Annals of tropical medicine and parasitology.